Literature DB >> 32437885

Ketamine's dose related multiple mechanisms of actions: Dissociative anesthetic to rapid antidepressant.

Eli Lavender1, Mika Hirasawa-Fujita1, Edward F Domino2.   

Abstract

Ketamine induces safe and effective anesthesia and displays unusual cataleptic properties that gave rise to the term dissociative anesthesia. Since 1970, clinicians only utilized the drug as an anesthetic or analgesic for decades, but ketamine was found to have rapid acting antidepressant effects in 1990s. Accumulated evidence exhibits NMDAR antagonism may not be the only mechanism of ketamine. The contributions of AMPA receptor, mTor signal pathway, monoaminergic system, sigma-1 receptor, cholinergic, opioid and cannabinoid systems, as well as voltage-gated calcium channels and hyperpolarization cyclic nucleotide gated channels are discussed for the antidepressant effects. Also the effects of ketamine's enantiomers and metabolites are reviewed. Furthermore ketamine's anesthetic and analgesic mechanisms are briefly revisited. Overall, pharmacology of ketamine, its enantiomers and metabolites is very unique. Insight into multiple mechanisms of action will provide further development and desirable clinical effects of ketamine.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dissociative effects; Enantiomers; Ketamine; Mechanisms of action; Metabolites; Rapid antidepressant

Year:  2020        PMID: 32437885     DOI: 10.1016/j.bbr.2020.112631

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  7 in total

1.  Response to intravenous racemic ketamine after switch from intranasal (S)-ketamine on symptoms of treatment-resistant depression and post-traumatic stress disorder in Veterans: A retrospective case series.

Authors:  Sean Bentley; Hewa Artin; Eamonn Mehaffey; Fred Liu; Kevin Sojourner; Andrew Bismark; David Printz; Ellen E Lee; Brian Martis; Sharon De Peralta; Dewleen G Baker; Jyoti Mishra; Dhakshin Ramanathan
Journal:  Pharmacotherapy       Date:  2022-02-24       Impact factor: 4.705

2.  Effects of intranasal (S)-ketamine on Veterans with co-morbid treatment-resistant depression and PTSD: A retrospective case series.

Authors:  Hewa Artin; Sean Bentley; Eamonn Mehaffey; Fred X Liu; Kevin Sojourner; Andrew W Bismark; David Printz; Ellen E Lee; Brian Martis; Sharon De Peralta; Dewleen G Baker; Jyoti Mishra; Dhakshin Ramanathan
Journal:  EClinicalMedicine       Date:  2022-05-06

3.  Exploring pharmacological options for adolescent depression: a preclinical evaluation with a sex perspective.

Authors:  Sandra Ledesma-Corvi; Elena Hernández-Hernández; M Julia García-Fuster
Journal:  Transl Psychiatry       Date:  2022-06-01       Impact factor: 7.989

4.  Ketamine beyond anesthesia: Antidepressant effects and abuse potential.

Authors:  Keith A Trujillo; Sergio D Iñiguez
Journal:  Behav Brain Res       Date:  2020-07-31       Impact factor: 3.332

Review 5.  Clinical Uses of Ketamine in Children: A Narrative Review.

Authors:  Anoushka Bali; Ashujot Kaur Dang; Daniel A Gonzalez; Rajeswar Kumar; Saba Asif
Journal:  Cureus       Date:  2022-07-20

6.  Microglia enable mature perineuronal nets disassembly upon anesthetic ketamine exposure or 60-Hz light entrainment in the healthy brain.

Authors:  Alessandro Venturino; Rouven Schulz; Héctor De Jesús-Cortés; Margaret E Maes; Bálint Nagy; Francis Reilly-Andújar; Gloria Colombo; Ryan John A Cubero; Florianne E Schoot Uiterkamp; Mark F Bear; Sandra Siegert
Journal:  Cell Rep       Date:  2021-07-06       Impact factor: 9.995

Review 7.  Ketamine: Neuroprotective or Neurotoxic?

Authors:  Divya Choudhury; Anita E Autry; Kimberley F Tolias; Vaishnav Krishnan
Journal:  Front Neurosci       Date:  2021-09-10       Impact factor: 4.677

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.